Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Harmonix is an early-stage venture capital firm founded to advance human health through innovations in healthcare, life sciences, and deep technology. The firm has a multidisciplinary team with over 70 years of combined experience, including entrepreneurs, scientists, and industry experts. They manage a portfolio of 8 companies, focusing on pre-seed to Series A investments.
Harmonix invests in technological breakthroughs within healthcare, biotech, AI, and frontier technology sectors. They target exceptional entrepreneurs and innovative companies, employing an evidence-based due diligence framework to evaluate potential investments. The firm typically engages in pre-seed, seed, seed-plus, and Series A funding rounds.
Notable portfolio companies include Caresyntax, a digital surgery platform; Bit.bio, a synthetic and stem cell therapy platform; Loft Orbital, which provides end-to-end space mission services; Sorcero, an AI-powered medical data insights platform; Insilico Medicine, focused on AI drug discovery; xCures, an AI precision medicine platform; Abalone Bio, specializing in antibody drug discovery; and Bioz, an AI-driven search engine for life science research tools.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.